10/27/2026 | Press release | Archived content
BostonGene, developer of an AI model for tumor and immune biology, today announced that Ferran Prat, PhD, JD, Chief Commercial Officer, will moderate the "Ecosystem of External Innovation" panel at the Longwood Healthcare Leaders Boston CEO conference taking place November 2 - 3, 2026, in Boston. Dr. Prat will join executive leaders to engage in strategic dialogue and explore cross-industry partnerships with biopharma CEOs, heads of research and development, life science investors, and leading academics.
The panel will examine how industry leaders evaluate external scientific assets, navigate cross-border data and regulatory dynamics, and leverage AI to optimize development and deliver meaningful outcomes to patients.
"External innovation is crucial for accelerating the next generation of precision therapies," said Ferran Prat, PhD, JD, Chief Commercial Officer at BostonGene. "We need to evaluate external science on the strength of its evidence, define what would justify advancing or stopping a program, and apply clear standards for data quality and scientific validation when using AI."
Session Details:
Date & Time: Monday, November 2 | 8:30 AM
Title: Ecosystem of External Innovation
Moderator:
Ferran Prat, CCO, BostonGene
Featured Panelists:
Nadim Ahmed, CEO, Cullinan Therapeutics
Jeanne Cunicelli, President, UPMC Enterprises
Scott Requadt, CEO, Prolium Bioscience
For more information on the conference or to view the full agenda, visit https://www.longwoodhealthcareleaders.com/bostonceo.